Cargando…

Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Development of a Nomogram in Breast Cancer Patients

PURPOSE: The objective of this study was to explore the prognostic significance of pretreatment hematologic parameters in predicting disease-free survival (DFS) of breast cancer patients. MATERIALS AND METHODS: The medical records of 440 breast cancer patients in Shandong Cancer Hospital and Institu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Ying, Zhang, Yong, Li, Li, Zhang, Shaotong, Liu, Ning, Yuan, Shuanghu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719671/ https://www.ncbi.nlm.nih.gov/pubmed/34976782 http://dx.doi.org/10.3389/fonc.2021.650980

Ejemplares similares

Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet−to−Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta−analysis
por: Leng, Jiali, et al.
Publicado: (2022)

Prognostic value of lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio in follicular lymphoma: a retrospective cohort study
por: Lee, Shing Fung, et al.
Publicado: (2017)

Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with glioma: a meta-analysis
por: Wang, Yan, et al.
Publicado: (2023)

Prognostic value of preoperative lymphocyte-to-monocyte ratio in gallbladder carcinoma patients and the establishment of a prognostic nomogram
por: Deng, Yan, et al.
Publicado: (2020)

Prognostic value of pretreatment lymphocyte‐to‐monocyte ratio in patients with advanced oral cavity cancer
por: Supanimitjaroenporn, Pasawat, et al.
Publicado: (2022)

Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis
por: Ni, Liwei, et al.
Publicado: (2019)

Prognostic Value of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio, and Combined Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Stage IV Advanced Gastric Cancer
por: Wang, Huan, et al.
Publicado: (2020)

Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio in Lung Cancer: A Systematic Review and Meta-Analysis
por: Jin, Jing, et al.
Publicado: (2021)

Predictive Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Platelet-to-Lymphocyte Ratio in the Survival of Nasopharyngeal Carcinoma Patients
por: Chen, Yibiao, et al.
Publicado: (2021)

Prognostic Evaluation of Metastasis-Related Lymphocyte/Monocyte Ratio in Stage Ⅰ-Ⅲ Breast Cancer Receiving Chemotherapy
por: Zhang, Zihan, et al.
Publicado: (2022)

Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma
por: Lee, Su-Min, et al.
Publicado: (2015)

Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in HER2-Positive Metastatic Breast Cancer
por: Shao, Bin, et al.
Publicado: (2022)

Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with urologic tumors: A PRISMA-compliant meta-analysis
por: Li, Jialin, et al.
Publicado: (2019)

Prognostic significance of pretreatment lymphocyte/monocyte ratio in retroperitoneal liposarcoma patients after radical resection
por: Luo, Peng, et al.
Publicado: (2018)

Pretreatment lymphocyte-to-monocyte ratio as a prognostic factor and influence on dose-effect in fractionated stereotactic radiotherapy for oligometastatic brain metastases in non-small cell lung cancer patients
por: Chen, Tian, et al.
Publicado: (2023)

Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors
por: Rottier, Pauline, et al.
Publicado: (2023)

Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in Unresectable or Metastatic Esophageal Cancer Patients With Anti-PD-1 Therapy
por: Gao, Yiming, et al.
Publicado: (2022)

Prognostic Value of Peripheral Blood Lymphocyte/monocyte Ratio in Lymphoma
por: Gao, Feiqiong, et al.
Publicado: (2021)

Prognostic Nomograms in Oral Squamous Cell Carcinoma: The Negative Impact of Low Neutrophil to Lymphocyte Ratio
por: Mattavelli, Davide, et al.
Publicado: (2019)

The Prognostic Value of Neutrophil-to-lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Metastatic Gastric Cancer Treated with Systemic Chemotherapy
por: Zhou, Danyang, et al.
Publicado: (2020)

Lymphocyte to Monocyte Ratio: A New Independent Prognostic Factor in Bladder Cancer Progression?
por: Ferro, Matteo, et al.
Publicado: (2021)

Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Pediatric Parotid Cancer
por: Seng, Dongjie, et al.
Publicado: (2019)

Potential Clinical Value of Pretreatment De Ritis Ratio as a Prognostic Biomarker for Renal Cell Carcinoma
por: Li, Jinze, et al.
Publicado: (2021)

The prognostic value of monocyte-to-lymphocyte ratio in peritoneal dialysis patients
por: Yang, Yan, et al.
Publicado: (2023)

Prognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinoma
por: Li, Guang-Jun, et al.
Publicado: (2016)

Prognostic Value of the Platelet-to-Lymphocyte Ratio in Patients With Melanoma: A Meta-Analysis
por: Zhang, Feng, et al.
Publicado: (2020)

Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection: A multicenter study of 333 patients
por: Ge, Ming-Yang, et al.
Publicado: (2023)

Prognostic value of pretreatment serum albumin−globulin ratio in urothelial carcinoma: A systematic review and meta-analysis
por: Xia, Zhongyou, et al.
Publicado: (2022)

The value of a new prognostic model developed by lymphocyte-monocyte ratio and platelet-monocyte ratio in peripheral T-cell lymphoma
por: Zhang, Yan, et al.
Publicado: (2021)

Lymphocyte-to-Monocyte Ratio Is the Independent Prognostic Marker of Progression in Patients Undergoing BCG-Immunotherapy for Bladder Cancer
por: Adamkiewicz, Mateusz, et al.
Publicado: (2021)

Efficacy of Postoperative FOLFOX Versus XELOX Chemotherapy for Gastric Cancer and Prognostic Value of Platelet–Lymphocyte Ratio in Patients Receiving XELOX
por: Yin, Xin, et al.
Publicado: (2020)

Prognostic impact of pretreatment lymphocyte-to-monocyte ratio in advanced epithelial cancers: a meta-analysis
por: Mao, Yiming, et al.
Publicado: (2018)

Prognostic value of neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte ratios and Glasgow prognostic score in osteosarcoma: A meta-analysis
por: Peng, Li-Peng, et al.
Publicado: (2022)

Development and Validation of Nomograms Based on Gamma-Glutamyl Transpeptidase to Platelet Ratio for Hepatocellular Carcinoma Patients Reveal Novel Prognostic Value and the Ratio Is Negatively Correlated With P38MAPK Expression
por: Luo, Dingan, et al.
Publicado: (2020)

Prognostic value of the combination of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratio on mortality in patients on maintenance hemodialysis
por: Liao, Jiaxian, et al.
Publicado: (2022)

The prognostic value of the lymphocyte-to-monocyte ratio for high-risk papillary thyroid carcinoma
por: Song, Linlin, et al.
Publicado: (2019)

Prognostic role of pretreatment platelet to lymphocyte ratio in urologic cancer
por: Wang, Jianfeng, et al.
Publicado: (2017)

Prognostic Value of the Lymphocyte‐to‐Monocyte Ratio in Patients with Parotid Gland Carcinoma
por: Mikoshiba, Takuya, et al.
Publicado: (2020)

Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysis
por: Gong, Jun, et al.
Publicado: (2019)

Value of the Ratio of Monocytes to Lymphocytes for Monitoring Tuberculosis Therapy
por: Wang, Wei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hu5bvlumb0ps6ae0i6n89nutpg